XTX Topco’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $853K | Buy |
95,201
+7,812
| +9% | +$70K | 0.04% | 759 |
|
|
2025
Q1 | $655K | Buy |
87,389
+66,320
| +315% | +$497K | 0.03% | 827 |
|
|
2024
Q4 | $158K | Sell |
21,069
-10,601
| -33% | -$79.7K | 0.01% | 1635 |
|
|
2024
Q3 | $241K | Sell |
31,670
-125,276
| -80% | -$952K | 0.02% | 1327 |
|
|
2024
Q2 | $970K | Buy |
156,946
+117,607
| +299% | +$727K | 0.08% | 368 |
|
|
2024
Q1 | $200K | Sell |
39,339
-17,065
| -30% | -$86.7K | 0.03% | 1179 |
|
|
2023
Q4 | $338K | Buy |
56,404
+24,571
| +77% | +$147K | 0.07% | 532 |
|
|
2023
Q3 | $225K | Sell |
31,833
-69,112
| -68% | -$489K | 0.04% | 947 |
|
|
2023
Q2 | $711K | Buy |
100,945
+61,166
| +154% | +$431K | 0.13% | 199 |
|
|
2023
Q1 | $332K | Buy |
+39,779
| New | +$332K | 0.07% | 576 |
|
|
2022
Q3 | – | Sell |
-15,988
| Closed | -$169K | – | 1105 |
|
|
2022
Q2 | $169K | Buy |
+15,988
| New | +$169K | 0.07% | 509 |
|